Differential increase in Fos immunoreactivity in hypothalamic and septal nuclei by arginine8-vasopressin and desglycinamide9-arginine8-vasopressin

Neuroscience

Volumn 91, Issue 4, 1999, Pages 1331-1341

  Lanca A J ^a,b   Wu, P H ^a   Jung, B ^a   Liu, J F ^a   Ng, V ^a   Kalant, H ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Arginine8 vasopressin; Des Gly9 Arg8 vasopressin; Fos immunoreactivity; Hypothalamic nuclei; Rat brain; Septum

Indexed keywords

ARGIPRESSIN; ARGIPRESSIN[DEGLYCINAMIDE]; VASOPRESSIN V1 RECEPTOR;

ALCOHOL TOLERANCE; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE EXPRESSION; IMMUNOREACTIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; ONCOGENE C FOS; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SEPTUM NUCLEUS; SUBCUTANEOUS DRUG ADMINISTRATION; SUPRACHIASMATIC NUCLEUS; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS;

ANIMALS; ARGININE VASOPRESSIN; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SEPTUM PELLUCIDUM; SUBFORNICAL ORGAN;

EID: 0032904038     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00709-X     Document Type: Article

References (76)

1. Ang V.T.Y., Jenkins J.S. Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin and desglycinamide arginine-vasopressin in the dog. J. Endocrinol. 93:1982;319-325.
2. Begley D.J. Peptides and the blood-brain barrier: the status of our understanding. Ann. N. Y. Acad. Sci. 739:1994;89-100.
3. Biegon A., Terlou M., Voorhuis Th. D., De Kloet E.R. Arginine-vasopressin binding sites in rat brain: a quantitative autoradiographic study. Neurosci. Lett. 44:1984;229-234.
4. Bohus B. Effects of desglycinamide-lysine vasopressin (DG-LVP) on sexually motivated T-maze behavior of the male rat. Horm. Behav. 8:1977;52-61.
5. Bohus B., Ader R., de Wied D. Effects of vasopressin on active and passive avoidance behavior. Horm. Behav. 3:1972;191-197.
6. Bookin H.B., Pfeifer W. Effect of lysine vasopressin on pentylenetetrazol-induced retrograde amnesia in rats. Pharmac. Biochem. Behav. 7:1977;51-54.
7. Brinton R.E., Gee K.W., Wamsley J.K., Davis T.P., Yamamura H.I. Regional distribution of putative vasopressin receptors in rat brain and pituitary by quantitative autoradiography. Proc. natn. Acad. Sci. U.S.A. 81:1984;7248-7252.
8. Carlson S.H., Beitz A., Osborn J.W. Intragastric hypertonic saline increases vasopressin and central Fos immunoreactivity in conscious rats. Am. J. Physiol. 272(41):1997;R750-R758.
9. De Vries G.J., Buijs R.M. The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum. Brain Res. 273:1983;307-317.
10. de Wied D., Bohus B. Long term and short term effects on a retention of a conditioned avoidance response in rats by treatment with long-acting pitressin and alpha-MSH. Nature. 212:1966;1484-1486.
11. de Wied D., Greven H.M., Lande S., Witter A. Dissociation of the behavioral and endocrine effects of lysine vasopressin by tryptic digestion. Br. J. Pharmac. 45:1972;118-122.
12. de Wied D., Gaffori O., Van Ree J.M., DeJong W. Vasopressin antagonists block peripheral as well as central vasopressin receptors. Pharmac. Biochem. Behav. 21:1984;393-400.
13. Dorsa D.M., Brot M.D., Shewey L.M., Meyers K.M., Szot P., Miller M.A. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain. Synapse. 2:1988;205-211.
14. Dragunow M., Robertson H.A. Generalized seizures induce c-fos protein(s) in mammalian neurons. Neurosci. Lett. 82:1987;157-161.
15. Felix D., Schelling P. Increased sensitivity of neurons to angiotensin II in SHR compared to WKY rats. Brain Res. 252:1982;63-69.
16. 3H]oxytocin-binding sites in the Wistar rat brain studied by autoradiography. Neuroscience. 20:1987;599-614.
17. Giri P.R., Dave J.R., Tabakoff B., Hoffman P.L. Arginine vasopressin induces the expression of c-fos in mouse septum and hippocampus. Molec. Brain Res. 7:1990;131-137.
18. Greenberg M.E., Ziff E.B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 311:1984;433-438.
19. Hoffman P.L., Ritzmann R.F., Tabakoff B. Neurohypophyseal peptide influence on ethanol tolerance and acute effects of ethanol. Pharmac. Biochem. Behav. 13(Suppl 1):1980;279-284.
20. Hoffman P.L., Ritzmann R.F., Walter R., Tabakoff B. Arginine vasopressin maintains ethanol tolerance. Nature. 276:1978;614-616.
21. Hoffman W.E., Phillips M.I., Schmid P.G., Falcon J., Weet J.F. Antidiuretic hormone release and the pressor response to central angiotensin II and cholinergic stimulation. Neuropharmacology. 16:1977;463-472.
22. Hostetter G., Jubb S.L., Kozlowski G.P. Vasopressin affects the behavior of rats in a positively-rewarded discrimination task. Life Sci. 21:1977;1323-1328.
23. Hyman S. E., Kosofsky B. E., Nguyen T. V., Cohen B. M. and Comb M. J. (1993) Everything activates c-fos - how can it matter? In Activation of Immediate Early Genes by Drugs of Abuse (eds Grzanna R. and Brown R. M.), NIDA Res. Monogr. 125, pp. 25-38. NIDA, Rockville, Maryland.
24. Ishizawa H.B., Tabakoff B., Mefford I.N., Hoffman P.L. Reduction of arginine vasopressin binding sites in mouse lateral septum by treatment with 6-hydroxydopamine. Brain Res. 507:1990;189-194.
25. Jakab R.L., Naftolin F., Leranth C. Convergent vasopressinergic and hippocampal input onto somatospiny neurons of the rat lateral septal area. Neuroscience. 40:1991;413-421.
26. Jhamandas J.H., Raby W., Rogers J., Buijs R.M., Renaud L.P. Diagonal band projection towards the hypothalamic supraoptic nucleus: light and electron microscopic observations in the rat. J. comp. Neurol. 282:1989;15-23.
27. Johnson A.E., Audigier S., Rossi F., Jard S., Tribollet E., Barberis C. Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist. Brain Res. 622:1993;9-16.
28. Junig J.T., Abood L.G., Skrobala A.M. Two classes of arginine vasopressin binding sites on rat brain membranes. Neurochem. Res. 10:1985;1187-1202.
29. Jurzak M., Müller A.R., Gerstberger R. Investigation of vasopressin receptors in cells from circumventricular organs using calcium measurements. Soc. Neurosci. Abstr. 20:1994;1060.
30. Kalant H. Current state of knowledge about the mechanisms of alcohol tolerance. Addiction Biol. 1:1996;133-141.
31. Keil L.C., Summy-Long J., Severs W.B. Release of vasopressin by angiotensin II. Endocrinology. 96:1975;1063-1065.
32. Kovács G.L., de Wied D. Peptidergic modulation of learning and memory processes. Pharmac. Rev. 46:1994;269-291.
33. Kovács G.L., Vecsei L., Telegdy G. Opposite action of oxytocin to vasopressin in passive avoidance behaviour in rats. Physiol. Behav. 20:1978;801-802.
34. Lança A.J., Irving W.J., Wu P.H., Kalant H., Saint-Cyr J.A. Ascending projections from the dorsal (DR) and median raphe (MR) nuclei: possible functional implications with respect to ethanol tolerance. Soc. Neurosci. Abstr. 19:1993;1059.
35. Lança A.J., Grupp L.A., Israel Y. Reduction of voluntary alcohol consumption in the rat by transplantation of hypothalamic grafts. Brain Res. 632:1993;287-295.
36. 9-lysine vasopressin on suppression of memory by puromycin. Proc. natn. Acad. Sci. U.S.A. 69:1972;558-560.
37. Le Moal M., Dantzer R., Mormede P., Baduel A., Le Brun C., Ettenberg A., van der Kooy D., Wenger J., Deyo S., Koob G.F., Bloom F.E. Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and hypothesis. Psychoneuroendocrinology. 9:1984;319-341.
38. 8]-vasopressin and serotonin on ethanol tolerance. Eur. J. Pharmac. 80:1982;337-345.
39. Lind R.W., Van Hoesen G.W., Johnson A.K. An HRP study of the connections of the subfornical organ of the rat. J. comp. Neurol. 210:1982;265-277.
40. Messing R.B., Sparber S.B. Des-Gly-vasopressin improves acquisition and slows extinction of autoshaped behavior. Eur. J. Pharmac. 89:1983;43-51.
41. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. A. Rev. Neurosci. 14:1991;421-451.
42. Müller R., Bravo R., Burckhardt J., Curran T. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature. 312:1984;716-720.
43. Nicoll R.A., Barker J.L. Excitation of supraoptic neurosecretory cells by angiotensin II. Nature New Biol. 233:1971;172-174.
44. Oldendorf W. H. (1975) Permeability of the blood-brain barrier. In The Nervous System (ed. Tower D. B.), Vol. 1, pp. 279-289. Raven, New York.
45. Pardridge W.M. Neuropeptides and the blood-brain barrier. A. Rev. Physiol. 45:1983;73-82.
46. Paxinos G. and Watson C. (1992) The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic, San Diego.
47. Pfeifer W., Bookin H.B. Vasopressin antagonizes retrograde amnesia in rats following electroconvulsive shock. Pharmac. Biochem. Behav. 9:1978;261-263.
48. Phillips P.A., Abrahams J.M., Kelly J.M., Mooser V., Trinder D., Johnston C.I. Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands. Endocrinology. 126:1990;1478-1484.
49. 1 receptor antagonist. Neuroscience. 27:1988;749-761.
50. 1 vasopressin receptors in the lateral septum of the rat brain. Proc. natn. Acad. Sci. U.S.A. 84:1987;7778-7782.
51. 2-induced retrograde amnesia in rats. Physiol. Behav. 13:1974;381-388.
52. Rinaman L., Stricker E.M., Hoffman G.E., Verbalis J.G. Central c-fos expression in neonatal and adult rats after subcutaneous injection of hypertonic saline. Neuroscience. 79:1997;1165-1175.
53. Sakai K.K., Marks B.H., George J., Koestner A. Specific angiotensin II receptors in organ-cultured canine supra-optic nucleus cells. Life Sci. 14:1974;1337-1344.
54. Sofroniew M.V., Weindl A. Projections from the parvocellular vasopressin- and neurophysin-containing neurons of the suprachiasmatic nucleus. Am. J. Anat. 153:1978;391-429.
55. Speisky M.B., Kalant H. Site of interaction of serotonin and desglycinamide-arginine-vasopressin in maintenance of ethanol tolerance. Brain Res. 326:1985;281-290.
56. Staiger J.F., Nürnberger F. Pattern of afferents to the lateral septum in the guinea pig. Cell Tiss. Res. 257:1989;471-490.
57. Stegner H., Artman H.G., Leake R.D., Fisher D.A. Does DDAVP (1-desamino-8-D-arginine-vasopressin) cross the blood-CSF barrier? Neuroendocrinology. 37:1983;262-265.
58. 1 characteristics mediate the maintenance of ethanol tolerance by vasopressin. J. Pharmac. exp. Ther. 247:1988;536-541.
59. 6]arginine vasopressin-(4-9) and nerve growth factor on maintenance of functional tolerance to ethanol in mice. Eur. J. Pharmac. 199:1991;131-134.
60. Szabó G., Nunley K.R., Hoffman P.L. Antisense oligonucleotide to c-fos blocks the ability of arginine vasopressin to maintain ethanol tolerance. Eur. J. Pharmac. 306:1996;67-72.
61. Tanaka J., Saito H., Seto K. Involvement of the septum in the regulation of paraventricular vasopressin neurons by the subfornical organ in the rat. Neurosci. Lett. 92:1988;187-191.
62. Terada Y., Marumo F. Recent advances in vasopressin receptors and signal transduction system. Nippon Rinsho. 51:1993;2655-2660.
63. Thibonnier M., Auzan C., Madhun Z., Wilkins P., Berti-Mattera L., Clauser E. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J. biol. Chem. 269:1994;3304-3310.
64. Tribollet E., Barberis C., Jard S., Dubois-Dauphin M., Dreifuss J.J. Localization and pharmacological characterization of high affinity binding sites for vasopressin and oxytocin in the rat brain by light microscopic autoradiography. Brain Res. 442:1988;105-118.
65. Van Bree J.B., Tio S., de Boer A.G., Danhof M., Verhoef J.C., Breimer D.D. Transport of desglycinamide-arginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methodology. Pharmac. Res. 7:1990;293-298.
66. Van Leeuwen F.W., Caffe R. Vasopressin-immunoreactive cell bodies in the bed nucleus of the stria terminalis of the rat. Cell Tiss. Res. 228:1983;525-534.
67. 5Tyr(ME)VP in the rat brain, pituitary and kidney. Neurosci. Lett. 80:1987;121-126.
68. Van Wimersma Greidanus T.B., Woutersen R.A., de Wied D. Stimulation and inhibition of corticotrophin release in rats after intracerebroventricular administration of vasopressin analogs. J. Endocrinol. 72:1977;10p.
69. Van Wimersma Greidanus Tj. B., Bohus B., de Wied D. Effects of peptide hormones on behavior. Prog. Endocr. 273:1973;197-201.
70. 3H]vasopressin-labelled specific binding sites in the canary brain. Brain Res. 457:1988;148-153.
71. Wright J.W., Harding J.W. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res. Rev. 17:1992;227-262.
72. Wu P.H., Lança A.J., Jung B., Liu J.-F., Grupp L., Kalant H. Stimulation of c-fos expression in selective brain nuclei by exogenous arginine-8-vasopressin: quantitative immunocytochemical study. Soc. Neurosci. Abstr. 20:1994;1061.
73. 8-vasopressin. J. Pharmac. exp. Ther. 270:1994;802-808.
74. 8-vasopressin increases Fos in specific brain areas. Eur. J. Pharmac. 281:1995;263-269.
75. 8]-vasopressin (DGAVP). Alcoholism: Clin. exp. Res. 20:1996;53A.
76. 3H]-arginine vasopressin binding sites in rat brain. Life Sci. 32:1983;1919-1924.